These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 1827095
1. A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis. Aldons PM. J Antimicrob Chemother; 1991 Feb; 27 Suppl A():101-8. PubMed ID: 1827095 [Abstract] [Full Text] [Related]
2. Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis. Bachand RT. J Antimicrob Chemother; 1991 Feb; 27 Suppl A():91-100. PubMed ID: 1827107 [Abstract] [Full Text] [Related]
3. Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis. Guay DR, Craft JC. J Intern Med; 1992 Mar; 231(3):295-301. PubMed ID: 1532615 [Abstract] [Full Text] [Related]
4. Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis. Wettengel R, Vetter N, Waardenburg FA. J Antimicrob Chemother; 1993 Jun; 31(6):963-72. PubMed ID: 8360133 [Abstract] [Full Text] [Related]
5. A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis. Gaillat J. J Antimicrob Chemother; 1993 Mar; 31 Suppl C():139-51. PubMed ID: 8478305 [Abstract] [Full Text] [Related]
6. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin. Nalepa P, Dobryniewska M, Busman T, Notario G. Curr Med Res Opin; 2003 Mar; 19(5):411-20. PubMed ID: 13678478 [Abstract] [Full Text] [Related]
7. Clarithromycin in the treatment of bacterial relapses of chronic bronchitis. Dericoloso A, Sanduzzi A, Cuccurullo S, Sarno M, Bianco A, Moro RA. Riv Eur Sci Med Farmacol; 1991 Mar; 13(5-6):275-83. PubMed ID: 1840282 [Abstract] [Full Text] [Related]
8. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis. Hosie J, Quinn P, Smits P, Sides G. J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264 [Abstract] [Full Text] [Related]
9. The comparative efficacy and safety of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitis. Karma P, Pukander J, Penttilä M, Ylikoski J, Savolainen S, Olén L, Melén I, Löth S. J Antimicrob Chemother; 1991 Feb; 27 Suppl A():83-90. PubMed ID: 1827106 [Abstract] [Full Text] [Related]
10. A comparative study of clarithromycin and penicillin VK in the treatment of outpatients with streptococcal pharyngitis. Bachand RT. J Antimicrob Chemother; 1991 Feb; 27 Suppl A():75-82. PubMed ID: 1827105 [Abstract] [Full Text] [Related]
11. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection. Bradbury F. J Antimicrob Chemother; 1993 Jun; 31 Suppl E():153-62. PubMed ID: 8396087 [Abstract] [Full Text] [Related]
12. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Chodosh S, DeAbate CA, Haverstock D, Aneiro L, Church D. Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475 [Abstract] [Full Text] [Related]
13. A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia. Anderson G, Esmonde TS, Coles S, Macklin J, Carnegie C. J Antimicrob Chemother; 1991 Feb; 27 Suppl A():117-24. PubMed ID: 1827098 [Abstract] [Full Text] [Related]
14. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis. Gotfried M, Busman TA, Norris S, Notario GF. Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699 [Abstract] [Full Text] [Related]
15. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. Wilson R, Kubin R, Ballin I, Deppermann KM, Bassaris HP, Leophonte P, Schreurs AJ, Torres A, Sommerauer B. J Antimicrob Chemother; 1999 Oct; 44(4):501-13. PubMed ID: 10588312 [Abstract] [Full Text] [Related]
16. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis. Gotfried M, Notario G, Spiller J, Palmer R, Busman T. Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995 [Abstract] [Full Text] [Related]
17. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis. Langan CE, Zuck P, Vogel F, McIvor A, Peirzchala W, Smakal M, Staley H, Marr C. J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313 [Abstract] [Full Text] [Related]
18. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis. Adler JL, Jannetti W, Schneider D, Zhang J, Palmer R, Notario G. Clin Ther; 2000 Dec; 22(12):1410-20. PubMed ID: 11192133 [Abstract] [Full Text] [Related]